APA (7th ed.) Citation

H, K., S, O., F, R., G, B., S, F., C, B., . . . Shan, J. (2009). The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: How does it relate to the original lenalidomide experience in MDS? Cancer (0008543X), 115(22), 5202. https://doi.org/10.1002/cncr.24575

Chicago Style (17th ed.) Citation

H, Kantarjian, et al. "The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?" Cancer (0008543X) 115, no. 22 (2009): 5202. https://doi.org/10.1002/cncr.24575.

MLA (9th ed.) Citation

H, Kantarjian, et al. "The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?" Cancer (0008543X), vol. 115, no. 22, 2009, p. 5202, https://doi.org/10.1002/cncr.24575.